Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference
WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
Read More...
Read More...
Browsing Tag
Aclaris Therapeutics
Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic…
WAYNE, Pa., Dec. 03, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
Read More...
Read More...
Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021
Investigational New Drug Application for ATI-2138 Allowed WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Aclaris…
Read More...
Read More...
Aclaris Therapeutics to Participate in Upcoming Investor Conferences
WAYNE, Pa., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage…
Read More...
Read More...